Activation of the TGF-β signaling pathway promotes fibrosis in both muscle and skin tissues in DM patients, while in interstitial lung disease patients, TGF-β drives pulmonary fibroblast activation, resulting in collagen deposition and pulmonary fibrosis. Here, TGFB1 is linked to pulmonary fibrosis.